These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Structure and function of a potent lipopolysaccharide-binding antimicrobial and anti-inflammatory peptide. Wei L; Yang J; He X; Mo G; Hong J; Yan X; Lin D; Lai R J Med Chem; 2013 May; 56(9):3546-56. PubMed ID: 23594231 [TBL] [Abstract][Full Text] [Related]
26. The role of the multifunctional peptide LL-37 in host defense. Kai-Larsen Y; Agerberth B Front Biosci; 2008 May; 13():3760-7. PubMed ID: 18508470 [TBL] [Abstract][Full Text] [Related]
27. Pulmonary defense and the human cathelicidin hCAP-18/LL-37. Fahy RJ; Wewers MD Immunol Res; 2005; 31(2):75-89. PubMed ID: 15778507 [TBL] [Abstract][Full Text] [Related]
28. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. De Yang ; Chen Q; Schmidt AP; Anderson GM; Wang JM; Wooters J; Oppenheim JJ; Chertov O J Exp Med; 2000 Oct; 192(7):1069-74. PubMed ID: 11015447 [TBL] [Abstract][Full Text] [Related]
29. Vipericidins: a novel family of cathelicidin-related peptides from the venom gland of South American pit vipers. Falcao CB; de La Torre BG; Pérez-Peinado C; Barron AE; Andreu D; Rádis-Baptista G Amino Acids; 2014 Nov; 46(11):2561-71. PubMed ID: 25100358 [TBL] [Abstract][Full Text] [Related]
30. Biology and clinical relevance of naturally occurring antimicrobial peptides. Gallo RL; Murakami M; Ohtake T; Zaiou M J Allergy Clin Immunol; 2002 Dec; 110(6):823-31. PubMed ID: 12464945 [TBL] [Abstract][Full Text] [Related]
31. The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Nijnik A; Hancock RE Curr Opin Hematol; 2009 Jan; 16(1):41-7. PubMed ID: 19068548 [TBL] [Abstract][Full Text] [Related]
32. Comparative efficacy analysis of anti-microbial peptides, LL-37 and indolicidin upon conjugation with CNT, in human monocytes. Pradhan B; Guha D; Murmu KC; Sur A; Ray P; Das D; Aich P J Nanobiotechnology; 2017 Jun; 15(1):44. PubMed ID: 28606090 [TBL] [Abstract][Full Text] [Related]
34. Between good and evil: Complexation of the human cathelicidin LL-37 with nucleic acids. Zielke C; Nielsen JE; Lin JS; Barron AE Biophys J; 2024 Jun; 123(11):1316-1328. PubMed ID: 37919905 [TBL] [Abstract][Full Text] [Related]
35. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). Yang D; Chertov O; Oppenheim JJ J Leukoc Biol; 2001 May; 69(5):691-7. PubMed ID: 11358975 [TBL] [Abstract][Full Text] [Related]
36. Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide. Golec M Ann Agric Environ Med; 2007; 14(1):1-4. PubMed ID: 17655171 [TBL] [Abstract][Full Text] [Related]
37. Cathelicidins--a family of multifunctional antimicrobial peptides. Bals R; Wilson JM Cell Mol Life Sci; 2003 Apr; 60(4):711-20. PubMed ID: 12785718 [TBL] [Abstract][Full Text] [Related]
38. Diversity, Antimicrobial Action and Structure-Activity Relationship of Buffalo Cathelicidins. Brahma B; Patra MC; Karri S; Chopra M; Mishra P; De BC; Kumar S; Mahanty S; Thakur K; Poluri KM; Datta TK; De S PLoS One; 2015; 10(12):e0144741. PubMed ID: 26675301 [TBL] [Abstract][Full Text] [Related]
39. Avian host defense cathelicidins: structure, expression, biological functions, and potential therapeutic applications. Wang Y; Wang M; Shan A; Feng X Poult Sci; 2020 Dec; 99(12):6434-6445. PubMed ID: 33248558 [TBL] [Abstract][Full Text] [Related]
40. Human cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs. Nijnik A; Pistolic J; Wyatt A; Tam S; Hancock RE J Immunol; 2009 Nov; 183(9):5788-98. PubMed ID: 19812202 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]